SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (687)4/17/2001 6:01:33 PM
From: dalroi  Read Replies (1) | Respond to of 7143
 
well cryocell are running around to see that Ob Gyn pump their patients to buy storage for stemcells

CCEL

Cryo-Cell International, Inc. is engaged in cryogenic cellular storage and the design and development of cellular storage devices. The Company's current focus is on the processing and preservation of umbilical cord (U-Cord) blood stem cells for autologous/sibling use. Cryo-Cell has pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and, presently, the Company's mission of affordability for U-Cord blood preservation remains in effect. These technologies include a process for the storage of fractionated (separated) U-Cord stem cells and the development and patenting of the first computer-controlled, robotically operated cryogenic storage system.

cheers
Stefaan